Skip to main content

Published locations for Tildrakizumab for psoriasis scores high marks in phase III

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Tildrakizumab for psoriasis scores high marks in phase III

User login

  • Reset your password
  • /content/tildrakizumab-psoriasis-scores-high-marks-phase-iii
  • /edermatologynews/article/115945/psoriasis/tildrakizumab-psoriasis-scores-high-marks-phase-iii
  • /familypracticenews/article/115945/psoriasis/tildrakizumab-psoriasis-scores-high-marks-phase-iii
  • /internalmedicinenews/article/115945/psoriasis/tildrakizumab-psoriasis-scores-high-marks-phase-iii
  • /rheumatologynews/article/115945/psoriasis/tildrakizumab-psoriasis-scores-high-marks-phase-iii
  • /rheumatology/article/115945/psoriasis/tildrakizumab-psoriasis-scores-high-marks-phase-iii
  • /internalmedicine/article/115945/psoriasis/tildrakizumab-psoriasis-scores-high-marks-phase-iii
  • /dermatology/article/115945/psoriasis/tildrakizumab-psoriasis-scores-high-marks-phase-iii
  • /familymedicine/article/115945/psoriasis/tildrakizumab-psoriasis-scores-high-marks-phase-iii
  • /rheumatology/psoriatic-arthritis-resource-center/article/115945/psoriasis/tildrakizumab-psoriasis
  • /dermatology/psoriasiscollection/article/115945/psoriasis/tildrakizumab-psoriasis-scores-high-marks
  • /psoriatic-arthritis-icymi/article/115945/psoriasis/tildrakizumab-psoriasis-scores-high-marks-phase